Jul 9, 2018, 9:25 PM ETConference Presentation, Panel

Power Plant? Exploring the Cannabis Industry

Market Valuation: The U.S. cannabis industry is projected to reach $75 billion by 2030, with a five-year conservative outlook of $35 billion assuming universal state implementation.
Public Sentiment: 64% of U.S. citizens support legalization, representing the highest level of acceptance in 30 years of Gallup polling.
Economic Impact: California is expected to generate over $1 billion in tax revenue annually, while the sector is projected to create 283,000 new jobs.
Global Reach: Over 40 countries have implemented some form of legality, decriminalization, or medical programs.
U.S. Regulatory Status: Adult use is legal in 9 states plus DC, with a total of 30 states offering medical programs.
Key 2024 Political Shifts:
- Vermont legalized adult use via legislative action.
- Donald Trump pledged federal non-interference in state rights regarding cannabis.
- Former House Speaker John Boehner joined the board of a multi-state operator (MSO).
- Tiger Management led an investment in an ancillary cannabis company.

Sector Segmentation: The industry is divided into "plant-touching" (cultivation, retail, manufacturing) and "ancillary" sectors (e-commerce, financial services, compliance).
Technology Gap: Current operational technology is described as "Windows 98-esque" compared to modern Amazon standards, creating a massive opportunity for capital injection and efficiency.
Investment Strategy: Investors are favoring "operator-led" venture capital, where firms acquire equity in cultivation and retail to understand supply chain dynamics before deploying tech capital.
Capital Constraints: Federal illegality restricts access to traditional capital markets, driving up the cost of capital and creating a barrier that currently protects domestic operators from multinational competition (e.g., SAP, Oracle).
Future Competitive Landscape: The winner in the space will be defined by scale and low cost of capital, allowing operators to outcompete multinational corporations once federal barriers are removed.

Track-and-Trace Systems: Platforms like Metric have built state-mandated "seed-to-sale" systems that track every plant, SKU, and batch from cultivation to retail.
Real-Time Recall Capability: Regulators can execute product recalls instantly via these systems, a capability significantly faster than FDA or USDA processes which often require 48+ hours.
Data-Driven Regulation: State regulators are using this data to proactively regulate based on evidence, filling the regulatory void left by the absence of federal agencies (FDA, USDA, EPA) in the cannabis sector.
Operator Benefits: Comprehensive tracking systems reduce manual inventory counting (now done twice daily) and ensure compliance, though they impose a significant administrative burden on retailers.

Consumer Hardware: Pax (vaporizers) is positioning itself as a consumer technology company, integrating hardware with software apps to personalize the user experience, similar to the evolution from Blockbuster to Netflix.
Shift in Consumption: The market is pivoting from "stoner culture" (high potency, immediate intoxication) to therapeutic and lifestyle use (anti-inflammatory properties, sleep aid, non-psychoactive options).
Demographic Expansion: Target demographics are expanding to include seniors (for arthritis and sleep) and adults seeking alternatives to alcohol.
Brand Substitution: Data indicates a 15% substitution of beer and a direct substitution effect for opioids, with states reporting a 14% decrease in OxyContin prescriptions.
Packaging Evolution: The industry is moving away from unbranded "baggie" sales toward branded CPG (Consumer Packaged Goods) categories like edibles, tinctures, and vapes with specific use-case marketing.

Canada's Role as a Capital Hub: Due to federal legality, Canadian companies have access to robust public markets, banks, and institutional capital ($25B+ market cap), whereas U.S. companies face severe financial restrictions.
Regulatory Friction in Canada: The Canadian system is government-controlled (Crown Corporations), limiting brand differentiation and advertising, resulting in a market of limited SKUs and no major consumer brands.
U.S. Market Strategy: Major U.S. capital and brand-building potential are expected to remain in the U.S. (a $75B potential market vs. Canada's $2B), leading to a trend of U.S. companies listing on Canadian exchanges (e.g., CSE) to access capital before scaling domestically.
Global Import/Export: Canada is positioned to lead international exports (e.g., to Jamaica, Israel), while the U.S. remains legally isolated from cross-border trade.

IRS Code 280E: Cannabis operators cannot claim standard tax deductions (SG&A), limiting them to Cost of Goods Sold deductions only, which severely impacts retail margins.
Banking and Liquidity: The lack of federal banking access forces operators to manage cash-heavy operations, though regulatory bodies are beginning to show interest in crypto/blockchain solutions for compliance and tracking rather than circumvention.
Commodity Price Decline: Unrestricted cultivation (e.g., California's unlimited license model) has driven down commodity prices, creating a bifurcated market where value is captured through branding rather than raw material sales.
Oligopolistic Opportunity: States with limited licenses (e.g., Pennsylvania, Illinois, Maryland) are creating protected, oligopolistic markets that shield operators from price wars, similar to gaming licenses.

Federal Legalization: Speakers predict rapid changes to tax laws and banking access within the next few years, driven by political shifts (e.g., Biden administration, Trump's stated position).
Product Innovation: Cannabis ingredients (cannabinoids) are expected to be added to mainstream CPG products (e.g., cereal, beverages) within 20 years, moving away from psychoactive consumption.
Market Consolidation: The industry will consolidate around operators with the lowest cost of capital, similar to the liquor industry, with major CPG companies (e.g., Constellation Brands) expected to acquire domestic brands once federal barriers lower.
International Precedent: The success of state-level, data-driven regulation in the U.S. is expected to eventually influence and reshape federal regulatory frameworks, potentially offering a model for the FDA/USDA.